Sugi Predict

Sugi Predict / Compounds / SCHEMBL31151670

SCHEMBL31151670

SCHEMBL31151670

CC(C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(C)C)[C@@H](C)O

nearest known ligand 0.60

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ NTSR1 P30989 13/20 0.60
▸ NTSR2 O95665 5/20 0.58
▸ SORT1 Q99523 4/20 0.56
▸ F2 P00734 1/20 0.56
▸ OPRD1 P41143 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31151446 0.96 NTSR1 (0.59) NTSR1NTSR2SORT1F2OPRD1
SCHEMBL30361896 0.94 NTSR1 (0.61) NTSR1NTSR2SORT1OPRD1
SCHEMBL31151473 0.94 OPRD1 (0.61) F2OPRD1
SCHEMBL30361786 0.93 NTSR1 (0.61) NTSR1NTSR2SORT1OPRD1
SCHEMBL29414469 0.93 NTSR1 (0.62) NTSR1NTSR2SORT1OPRD1
SCHEMBL30361957 0.91 NTSR1 (0.60) NTSR1NTSR2SORT1OPRD1
SCHEMBL29894426 0.91 NTSR1 (0.63) NTSR1NTSR2SORT1F2OPRD1
SCHEMBL30623611 0.91 NTSR1 (0.65) NTSR1NTSR2SORT1OPRD1
SCHEMBL30294171 0.91 NTSR1 (0.64) NTSR1NTSR2SORT1OPRD1
SCHEMBL29940473 0.91 NTSR1 (0.64) NTSR1NTSR2SORT1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713002-A1 PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA Forssmann, Wolf-Georg (DE) 2026-03-25 — — EP disclosed
EP-4501347-A1 PEPTIDES FOR USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Forssmann, Wolf-Georg (DE) 2025-02-05 — — EP disclosed
EP-4501348-A1 PEPTIDES FOR USE IN THE IMPROVEMENT OF WELL-BEING Forssmann, Wolf-Georg (DE) 2025-02-05 — — EP disclosed
WO-2024235986-A1 PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA PHARIS BIOTEC GMBH (DE) 2024-11-21 — — WO disclosed
Send feedback